Our monthly webinars have health care experts sharing their clinical experiences with the use of peptides. The only way we can advance this science is by sharing our experiences about the benefits and limits of each peptide.
Dr. Dushyant Viswanthan spoke on BPC-157 and peptide therapies for intestinal health
Dr. Dushyant Viswanthan
Dr. David Calvo on his experience as board certified orthopedic surgeon using peptides for joint injection
August 26, 2020 at 8 PM EST
Dr. Mark Sherwood spoke on his peptide protocol on aging
Dr. Mark Sherwood
June 18, 2020 at 8 PM EST
Dr. Mark Gordon spoke on improving immunity against the coronavirus ( ionophore carriers, zinc and an update on the latest in the therapy of coronavirus)
Dr. Mark Gordon
April 23, 2020 at 8 PM EST
Dr. Luis Martinez spoke on peptides for the immune system
Dr. Luis Martinez
April 8, 2020 at 8 PM EST
Dr. Mary Ackerely spoke on her 7 years experience on VIP on mold, lung disease and others
Dr. Mary Ackerely
February 29, 2020 at 12PM EST
Nima Alvai, BPham, MPS speaking on over 10 years plus experience with AOD
Nima Alvai, BPham, MPS
September 24, 2019 8PM EST
Dr. Kent Holtorf on peptides in Lyme disease
Dr. Kent Holtorf on Peptides in Lyme Disease
August 27, 2019 at 8PM EST
Peptides that should not be used in cancer
Ryan Smith from Tailor Made Compounding
July 23, 2019 at 7PM EST
All of the webinars that are provided as a general guideline and for informational purpose only. The information is not intended to replace medical advise by other physicians. Readers and viewers are encouraged to confirm the information provided with other sources. Clinical Peptide Society has made every effort to have all lectures and statements made regarding Peptides comply with all FDA and State and Local laws. There are some Peptides which the FDA has not approved for compounding. These non FDA approved peptides that are discussed in the webinar is for scientific discussion. Dr. Edwin Lee, Dr. Luis Martinez, Clinical Peptide Society and the guest lecturer will not be liable for any direct or indirect damages from information provided.